Interventional studies for polycystic ovarian syndrome in children and adolescents.

Pediatric Health
Patricia Vuguin

Abstract

Polycystic ovarian syndrome (PCOS) is characterized by chronic anovulation, clinical and/or biochemical hyperandrogenism, which can be associated with altered insulin action. Symptoms usually begin around menarche, but onset after puberty may also occur as a result of environmental modifiers such as weight gain. The consequences of PCOS extend beyond the reproductive axis; there is a substantial risk for development of metabolic and cardiovascular abnormalities similar to the metabolic syndrome. Currently, the treatment is targeted to the patient's primary complaint such as hirsutism, restoration of regular menses or pregnancy. Pharmacological agents available for the treatment of hirsutism include androgen suppressors and peripheral androgen blockers. Recently, our understanding of the role of insulin resistance has led to the use of insulin-sensitizing medications as first-choice therapy. In conjunction with weight reduction and exercise, a pharmacologic reduction in insulin levels by either metformin or thiazolidinediones ameliorates both hyperinsulinemia and hyperandrogenism.

References

Jul 16, 1992·The New England Journal of Medicine·D A EhrmannZ Sheikh
Apr 16, 1988·Lancet·D W PolsonS Franks
Jul 1, 1987·European Journal of Obstetrics, Gynecology, and Reproductive Biology·C NappiU Montemagno
May 1, 1986·Clinics in Endocrinology and Metabolism·C Longcope
Jun 17, 1997·Annals of the New York Academy of Sciences·V DramusicY C Wong
Dec 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·R S LegroA Dunaif
Jun 3, 1999·Endocrinology and Metabolism Clinics of North America·S FranksD Willis
Oct 20, 1999·European Journal of Endocrinology·L FalsettiG Bugari
Jan 5, 2000·Clinical Endocrinology·K F MichelmoreM P Vessey
May 3, 2000·Clinical Endocrinology·P M SpritzerF Lhullier
Jan 10, 2001·The Journal of Pediatrics·V D LewyS Arslanian
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·L IbáñezF de Zegher
Aug 29, 2001·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·C J GlueckL Sieve-Smith
Nov 14, 2001·American Journal of Clinical Dermatology·J A Balfour, K McClellan
Jan 5, 2002·The American Journal of Medicine·R S LegroA Dunaif
Jun 18, 2002·Best Practice & Research. Clinical Endocrinology & Metabolism·Stephen Franks
Aug 2, 2002·Obstetrics and Gynecology·Tom LloydRichard S Legro
Feb 8, 2003·The Journal of Clinical Endocrinology and Metabolism·L J MoranR J Norman
May 10, 2003·Obstetrics and Gynecology·Ricardo Azziz
Jan 1, 1994·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·C M FarquharJ M Mitchell
Nov 1, 1961·The Journal of Clinical Endocrinology and Metabolism·D FERRIMAN, J D GALLWEY
Oct 22, 1963·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·T G BAKER
Oct 15, 2003·The Journal of Clinical Endocrinology and Metabolism·Miriam E SilfenSharon E Oberfield
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·M Ashraf GanieA C Ammini
Sep 15, 2004·Fertility and Sterility·UNKNOWN Practice Committee of the American Society for Reproductive Medicine
Sep 24, 2004·Best Practice & Research. Clinical Obstetrics & Gynaecology·Johanna S Archer, R Jeffrey Chang

❮ Previous
Next ❯

Citations

Aug 2, 2011·Archives of Gynecology and Obstetrics·Naira R Matevosyan
Jan 26, 2012·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Georgina L JonesWilliam L Ledger
Feb 8, 2014·Journal of Ovarian Research·Saira Saeed MirzaMasood Anwar Qureshi
Sep 17, 2016·International Journal of Endocrinology·Lali PkhaladzeNana Kvashilava
Oct 19, 2012·Current Opinion in Endocrinology, Diabetes, and Obesity·Katrina F Nicandri, Kathleen Hoeger
Aug 6, 2017·International Journal of Adolescent Medicine and Health·Mohammad H DabbaghmaneshHamidreza Tabatabaee
Jan 5, 2020·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Qinpei Ding, Min Liang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.